FDA Draft Guidelines for AI and the Need for Ethical Frameworks
This draft guidance does not, however, directly address ethical considerations as part of AI -model risks in drug product life cycles. Medical AI ...
Read the original at JAMA Network ↗
- Topics
- HealthcareGovernance & Risk Management
- Mentions
- FDA
- Tracked via
- “AI Risks”